These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 33327871)

  • 1. Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma.
    Zhou Z; Liu C; Liu K; Lv M; Li B; Lan Z; Chen W; Kang M
    Technol Cancer Res Treat; 2020; 19():1533033820980110. PubMed ID: 33327871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma.
    Zhou Z; Wu W; Li J; Liu C; Xiao Z; Lai Q; Qin R; Shen M; Shi S; Kang M
    BMC Cancer; 2021 Apr; 21(1):395. PubMed ID: 33845800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of miR-21-5p Key Target Genes and Pathways in Head and Neck Squamous Cell Carcinoma Based on TCGA Database and Bioinformatics Analysis.
    Shen M; Zhou Z; Li BB; Lv M; Feng C; Chen S; Shi S; Kang M; Zhao T
    Technol Cancer Res Treat; 2022; 21():15330338221081245. PubMed ID: 35235474
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthetic Evaluation of MicroRNA-1-3p Expression in Head and Neck Squamous Cell Carcinoma Based on Microarray Chips and MicroRNA Sequencing.
    Chen Y; Liu M; Jin H; Peng B; Dai L; Wang S; Xing H; Wang B; Wu Z
    Biomed Res Int; 2021; 2021():6529255. PubMed ID: 34485523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival.
    Xu X; Li M; Hu J; Chen Z; Yu J; Dong Y; Sun C; Han J
    J Cancer Res Ther; 2018; 14(7):1525-1534. PubMed ID: 30589034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression and biological information analysis of miR-375-3p in head and neck squamous cell carcinoma based on 1825 samples from GEO, TCGA, and peer-reviewed publications.
    Cen WN; Pang JS; Huang JC; Hou JY; Bao WG; He RQ; Ma J; Peng ZG; Hu XH; Ma FC
    Pathol Res Pract; 2018 Nov; 214(11):1835-1847. PubMed ID: 30243807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
    Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
    World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets.
    Shen Y; Liu J; Zhang L; Dong S; Zhang J; Liu Y; Zhou H; Dong W
    Biomed Res Int; 2019; 2019():7376034. PubMed ID: 31485443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of
    Tanaka N; Minemura C; Asai S; Kikkawa N; Kinoshita T; Oshima S; Koma A; Kasamatsu A; Hanazawa T; Uzawa K; Seki N
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel seven‑miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients.
    Lu L; Wu Y; Feng M; Xue X; Fan Y
    Mol Med Rep; 2019 Nov; 20(5):4340-4348. PubMed ID: 31545440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
    Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G
    World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma extracellular vesicle microRNA-491-5p as diagnostic and prognostic marker for head and neck squamous cell carcinoma.
    Panvongsa W; Siripoon T; Worakitchanon W; Arsa L; Trachu N; Jinawath N; Ngamphaiboon N; Chairoungdua A
    Cancer Sci; 2021 Oct; 112(10):4257-4269. PubMed ID: 34273216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Tumor Suppressive Genes Regulated by
    Oshima S; Asai S; Seki N; Minemura C; Kinoshita T; Goto Y; Kikkawa N; Moriya S; Kasamatsu A; Hanazawa T; Uzawa K
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
    Jin Y; Yang Y
    Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-501-5p acts as an energetic regulator in head and neck squamous cell carcinoma cells growth and aggressiveness via reducing CLCA4.
    Li B; Jiang YP; Zhu J; Meng L
    Mol Biol Rep; 2020 Mar; 47(3):2181-2187. PubMed ID: 32072405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.
    Vahabi M; Pulito C; Sacconi A; Donzelli S; D'Andrea M; Manciocco V; Pellini R; Paci P; Sanguineti G; Strigari L; Spriano G; Muti P; Pandolfi PP; Strano S; Safarian S; Ganci F; Blandino G
    J Exp Clin Cancer Res; 2019 Mar; 38(1):141. PubMed ID: 30925916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
    Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
    PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression level and prospective mechanism of miRNA-99a-3p in head and neck squamous cell carcinoma based on miRNA-chip and miRNA-sequencing data in 1, 167 cases.
    Wei GG; Guo WP; Tang ZY; Li SH; Wu HY; Zhang LC
    Pathol Res Pract; 2019 May; 215(5):963-976. PubMed ID: 30904360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Antitumor
    Minemura C; Asai S; Koma A; Kikkawa N; Kato M; Kasamatsu A; Uzawa K; Hanazawa T; Seki N
    Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Oncogenic Targets by Tumor-Suppressive
    Koma A; Asai S; Minemura C; Oshima S; Kinoshita T; Kikkawa N; Koshizuka K; Moriya S; Kasamatsu A; Hanazawa T; Uzawa K; Seki N
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.